Impact of Hepatitis C cure on risk of mortality and morbidity in people with HIV after ART initiation.
Open Access CRIS of the University of Bern · 01.08.2023
DOI: 10.48350/182680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Access CRIS of the University of Bern, erschienen am 01.08.2023. Verfasst von Mathieu Chalouni und 23 weiteren Autor:innen.
Abstract (Originalsprache)
OBJECTIVE Hepatitis C Virus (HCV) co-infection is associated with increased morbidity and mortality in people with HIV (PWH). Sustained virological response (SVR) decreases the risk of HCV-associated morbidity. We compared mortality, risk of AIDS-defining events, and non-AIDS non-liver (NANL) cancers between HCV co-infected PWH who reached SVR and mono-infected PWH. DESIGN Adult PWH from 21 cohorts in Europe and North America that collected HCV treatment data were eligible if they were HCV-free at time of ART initiation. METHODS Up to 10 mono-infected PWH were matched (on age, sex, date of ART start, HIV acquisition route, and being followed at the time of SVR) to each HCV co-infected PWH who reached SVR. Cox models were used to estimate relative hazards (HR) of all-cause mortality, AIDS-defining events, and NANL cancers after adjustment. RESULTS Among 62,495 PWH, 2,756 acquired HCV, of whom 649 reached SVR. For 582 of these, ≥1 mono-infected PWH could be matched, producing a total of 5,062 mono-infected PWH. The estimated HRs comparing HCV co-infected PWH who reached SVR with mono-infected PWH were 0.29 [95%CI 0.12-0.73] for mortality, 0.85 [0.42-1.74] for AIDS-defining events, and 1.21 [0.86-1.72] for NANL cancer. CONCLUSION PWH who reached SVR a short time after HCV acquisition were not at higher risk of overall mortality compared to mono-infected PWH. However, the apparent higher risk of NANL cancers in HCV co-infected PWH who reached SVR after a DAA-based treatment compared to mono-infected PWH, though compatible with a null association, suggests a need for monitoring of those events following SVR.
Schlagwörter
Zitieren
APA
Chalouni, M., Trickey, A., Ingle, M, S., Sepuvelda, M. A., Gonzalez, Juan, Rauch, A., Crane, M, H., Gill, John, M., Rebeiro, F, P., Rockstroh, J. K., Franco, R., Touloumi, G., Neau, D., Laguno, …, & Wittkop, L. (2023). Impact of Hepatitis C cure on risk of mortality and morbidity in people with HIV after ART initiation. Open Access CRIS of the University of Bern. https://doi.org/10.48350/182680
Vancouver
Chalouni M, Trickey A, Ingle, M S, Sepuvelda MA, Gonzalez, et al. Impact of Hepatitis C cure on risk of mortality and morbidity in people with HIV after ART initiation. Open Access CRIS of the University of Bern. 2023. doi:10.48350/182680
BibTeX
@article{Chalouni2023,
author = {Chalouni, Mathieu and Trickey, Adam and Ingle and M, Suzanne and Sepuvelda, Maria Antonia and Gonzalez and Juan and Rauch, Andri and Crane and M, Heidi and Gill and John, M and Rebeiro and F, Peter and Rockstroh, Jürgen K. and Franco, Ricardo and Touloumi, Giota and Neau, Didier and Laguno and Montserrat and Rappold, Michaela and Smit, Colette and Sterne, Jonathan A C and Wittkop, Linda},
title = {Impact of Hepatitis C cure on risk of mortality and morbidity in people with HIV after ART initiation},
journal = {Open Access CRIS of the University of Bern},
year = {2023},
doi = {10.48350/182680}
}
EUVIMED